BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240409T130000
DTEND;TZID=Europe/Stockholm:20240409T150000
DTSTAMP:20260422T141810
CREATED:20240212T162122Z
LAST-MODIFIED:20240226T142053Z
UID:162996-1712667600-1712674800@www.scilifelab.se
SUMMARY:Patentability and Strategies for Novel Therapeutic Oligonucleotides
DESCRIPTION:Welcome to this seminar to learn more about intellectual properties regarding therapeutic oligonucleotides and strategies how to protect your invention. The seminar is organized by OligoNova Hub and SciLifeLab Drug Discovery and Development and is a hybrid event (Zoom or in-person at GoCo House).    \n\n\n\nAgenda \n\n\n\nIntroduction \n\n\n\n\nOligoNova Hub/ScilifeLab DDD: Pär Matsson\, 5 min\n\n\n\nAstraZeneca: Peter Storm 20 min\n\n\n\nRibocure: (TBC) 20 min\n\n\n\n\nPatentability and Strategies for Therapeutic Oligonucleotides \n\n\n\n\nPotter Clarkson: Fiona Hey\, Kevin Rich and Louise Tottie\n\n\n\n\nPanel discussion questions  \n\n\n\n\nModerator: OligoNova Hub/DDD\n\n\n\n\nModerator: OligoNova Hub/DDD \n\n\n\nProtecting your innovation and future proofing your enterprise may well mean the difference between commercial success and disappointment. However\, it is not always obvious what IP you have\, what you might be able to protect and what is worthwhile protecting.  With a focus on oligonucleotide inventions\, we will guide you through the requirements for patentability\, highlighting the challenges associated with oligonucleotides and outlining an IP strategy that you can apply to help you to achieve your commercial goals. \n\n\n\nFor those that attend the seminar in person\, there will be time to continue the discussion after the program with IP attorneys and academic and industrial scientist working with therapeutic oligonucleotides. Coffee and cake will be served. \n\n\n\nPrior this hybrid event there will be a more general webinar (March 25\, at 1 pm) “Patent Fundamentals for Academia and Biotech Inventions”. \n\n\n\nOligoNova Hub offers industry-standard research and development capabilities to Swedish academic researchers\, helping to transform their ideas into new oligonucleotide therapies. OligoNova Hub is part of the national SciLifeLab Drug Discovery and Development infrastructure\, supporting academic researchers in drug discovery and development towards innovative commercial assets that will benefit patients. \n\n\n\n \n\n\n\nRegistration \n\n\n\nregistration\n\n\n\nOrganizer \n\n\n\nFredrik Wångsell\, Research Advisor at OligoNova Hub/SciLifeLab Oligonucleotide Therapeutics Unit
URL:https://www.scilifelab.se/event/patentability-and-strategies-for-novel-therapeutic-oligonucleotides/
LOCATION:GoCo House\, Allvar Gullstrand\, Entreprenörsstråket 10\, Mölndal\, 431 53\, Sweden
CATEGORIES:Event
ORGANIZER;CN="OligoNova - Part of the Drug Discovery and Development Platform":MAILTO:par.matsson@oligonova.org
END:VEVENT
END:VCALENDAR